Last scanned
Domain Age
Daily Visitors
Global Rank
Updated:
BYDUREON BCise® (exenatide extended-release) injectable suspension 2 mg | Home | For HCPs
Learn about dosing, safety, side effects, savings program and patient resources for BYDUREON BCise® (exenatide extended-release), a type 2 diabetes treatment option, from the official HCP website. (1 liked)
This website is hosted with Amazon.com, Inc., which reserves the following IP addresses for bydureonhcp.com: 52.85.144.21, 52.85.144.51, 52.85.144.54, 52.85.144.89. Moreover, DNS used with this website include ns-1309.awsdns-35.org, ns-1745.awsdns-26.co.uk, ns-492.awsdns-61.com, ns-531.awsdns-02.net. Subnet identifier ranges from 52.84.0.0 to 52.85.255.255. Classless Inter-Domain Routing (CIDR) is 52.84.0.0/15. ARIN net type is Reallocated.
Last scanned
Domain Age
Daily Visitors
Global Rank
ns-1309.awsdns-35.org
ns-1745.awsdns-26.co.uk
ns-492.awsdns-61.com
ns-531.awsdns-02.net
{{value}}
2010-02-19
2024-02-19
CSC CORPORATE DOMAINS, INC.
{{value}}
The registrar of bydureonhcp.com is CSC CORPORATE DOMAINS, INC. and the name expires on 2024-02-19. According to open source data, you can reach the owner at domains@astrazeneca.com but please make sure you have a good reason for unsolicited messages. Their country of residence is Sweden.
N/A
N/A
N/A
N/A
N/A
N/A
848.3K
2.1K
594.3K
N/A
N/A
N/A